T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NCI
851
DELISTED
Navigant Consulting, Inc.
NCI
| $47.5M | 0.01% |
3,192,780
+811,480
| +34% | +$11.5M |
|
852
Culp Inc
CULP
$43.2M
| $47.4M | 0.01% |
1,528,847
+25,230
| +2% | +$693K |
|
853
Zumiez
ZUMZ
$319M
| $47.2M | 0.01% |
1,773,810
-5,000
| -0.3% | -$154K |
|
854
Agios Pharmaceuticals
AGIO
$2B
| $47.2M | 0.01% |
424,854
-235,378
| -36% | -$25.4M |
|
855
Ethan Allen Interiors
ETD
$583M
| $46.9M | 0.01% |
1,780,430
+174,050
| +11% | +$4.49M |
|
856
Enpro
NPO
$7.12B
| $46.8M | 0.01% |
818,388
+2,900
| +0.4% | +$183K |
|
857
International Flavors & Fragrances
IFF
$21.4B
| $46.8M | 0.01% |
428,177
-8,200
| -2% | -$947K |
|
858
Aaon
AAON
$7.23B
| $46.8M | 0.01% |
3,116,571
-218,925
| -7% | -$3.47M |
|
|
CTT
859
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $46.7M | 0.01% |
4,039,960
+15,020
| +0.4% | +$177K |
|
860
Ligand Pharmaceuticals
LGND
$5.76B
| $46.7M | 0.01% |
742,250
+588,301
| +382% | +$32.1M |
|
|
RLD
861
DELISTED
REALD INC COM STK
RLD
| $46.7M | 0.01% |
3,785,614
-58,986
| -2% | -$738K |
|
|
ADXS
862
DELISTED
Advaxis Inc
ADXS
| $46.4M | 0.01% |
152,097
-14,117
| -8% | -$4.46M |
|
863
Fabrinet
FN
$20.3B
| $46.3M | 0.01% |
2,473,780
-744,370
| -23% | -$14M |
|
864
Sunstone Hotel Investors
SHO
$2.02B
| $46.1M | 0.01% |
3,070,814
+40,440
| +1% | +$636K |
|
865
Franklin Resources
BEN
$17.2B
| $45.9M | 0.01% |
936,299
+6,065
| +0.7% | +$311K |
|
|
AEGN
866
DELISTED
Aegion Corp
AEGN
| $45.7M | 0.01% |
2,414,020
-71,130
| -3% | -$1.31M |
|
867
Cummins
CMI
$87B
| $45.7M | 0.01% |
348,457
+8,580
| +3% | +$1.18M |
|
|
SLCA
868
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $45.4M | 0.01% |
1,545,909
+1,216,695
| +370% | +$41.1M |
|
869
Kite Realty
KRG
$5.31B
| $45.2M | 0.01% |
1,848,459
+65,990
| +4% | +$1.78M |
|
|
PARA
870
DELISTED
Paramount Global Class B
PARA
| $45.2M | 0.01% |
814,621
+9,680
| +1% | +$585K |
|
871
Cavco Industries
CVCO
$4.67B
| $45.1M | 0.01% |
597,780
+780
| +0.1% | +$55.9K |
|
|
HTWR
872
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $44.9M | 0.01% |
617,993
+232,100
| +60% | +$18.1M |
|
|
WPG
873
DELISTED
Washington Prime Group Inc.
WPG
| $44.6M | 0.01% |
366,119
+340,279
| +1,317% | +$44.9M |
|
874
Murphy USA
MUSA
$10.4B
| $44.4M | 0.01% |
795,238
+73,815
| +10% | +$4.63M |
|
875
Simpson Manufacturing
SSD
$8B
| $44.4M | 0.01% |
1,305,150
-4,300
| -0.3% | -$149K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.